'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.

Witt, Lucy S; Burd, Eileen M; Ozturk, Tugba; Satola, Sarah W; Weiss, David S; Jacob, Jesse T

Witt, Lucy S; Burd, Eileen M; Ozturk, Tugba; Satola, Sarah W; Weiss, David S; Jacob, Jesse T.

Afiliação

Witt LS; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.
Burd EM; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA 30303, USA.
Ozturk T; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.
Satola SW; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Weiss DS; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA.
Jacob JT; Emory School of Medicine, Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA.

J Antimicrob Chemother ; 77(11): 3212, 2022 10 28.

Article em En | MEDLINE | ID: mdl-36177772

Assuntos

Bacteriemia; Infecções por Klebsiella; Humanos; Klebsiella pneumoniae; Infecções por Klebsiella/tratamento farmacológico; Cefalosporinas/farmacologia; Cefalosporinas/uso terapêutico; Cefiderocol

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Klebsiella / Bacteriemia Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google